Results 11 to 20 of about 60,702 (193)

Neutrophil/Lymphocyte Ratio as a Biomarker of Response to H1-Antihistamine Therapy in Patients with Chronic Spontaneous Urticaria

Indian Journal of Dermatology
Backgrounds A large proportion of patients with chronic spontaneous urticaria (CSU) are resistant to a standard dose of antihistamine. Acknowledged biomarkers for identifying these patients have not been determined.
Xiaonan Qiu, Qiao Ran, Juanjuan Pan, Guozhen Tan   +3 more
doaj   +2 more sources

ANTIHISTAMINE MEDICATIONS: EFFICACY AND SAFETY OF USING IN PEDIATRIC PRACTICE

Педиатрическая фармакология, 2010
Therapy of allergic and many other diseases using antihistamine medications is the pressing topic in modern medicine. Since the first antihistamine medications were created, knowledge of effects from these drugs have expanded and changed.
L.R. Giniyatova, O.I. Pikuza, L.Е. Ziganshina   +2 more
doaj   +3 more sources

High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema

Clinical and Translational Allergy, 2019
Antihistamines are the most prescribed therapy in recurrent idiopathic angioedema, yet little is known about their efficacy. Herein, we report on clinical improvement with antihistamine therapy in 120 patients evaluating angioedema attack frequency.
Z. Hofman, Nikki van West, C. Hack, A. Knulst, C. Maas, H. Röckmann   +5 more
semanticscholar   +2 more sources

Effect of antihistamine-releasing contact lenses on ocular symptoms and treatment behavior in patients with seasonal allergic conjunctivitis: A retrospective study

Heliyon
Purpose: This study aimed to compare subjective allergic conjunctivitis symptoms and anti-allergic eye drop use patterns between antihistamine-releasing contact lens users and daily disposable soft contact lens users during Japan's hay fever season ...
Kenta Fujio, Jaemyoung Sung, Kunihiko Hirosawa, Masahiro Yamaguchi, Hiroshi Toshida, Keiji Inagaki, Gaku Ishida, Motozumi Itoi, Kazushige Sado, Hiroo Hayatsu, Hirayama Nobutaka, Junji Ono, Hidetaka Taniguchi, Masao Iwagami, Ken Nagino, Yuichi Okumura, Akie Midorikawa-Inomata, Yasutsugu Akasaki, Tianxiang Huang, Yuki Morooka, Tomoko Okuyama, Shintaro Nakao, Akira Murakami, Hiroyuki Kobayashi, Takenori Inomata   +24 more
doaj   +2 more sources

How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review

Drugs in Context
The off-label use of second-generation antihistamines, used outside of the formal indications authorized by regulatory authorities, in different age groups, doses or in special populations, is very common for many allergic, autoimmune and dermatological ...
Iñaki Izquierdo, Laia Casas, Susana Cabrera, Alberto Fernandez   +3 more
doaj   +2 more sources

Association between seizure susceptibility with type and optimal dose of antihistamine in patients with a febrile seizure; A retrospective cohort study in Gorgan, Iran [PDF]

Journal of Preventive Epidemiology
Introduction: Febrile seizures (FSs) are caused by the simultaneous consumption of first- and second-generation antihistamines, which prolong the process in some cases.
Hossein Gorzin, Seyed Ahmad Hosseini, Mousa Ghelichi-Ghojogh, Edris Ghezeljeh, Seyed Ali Aghapour   +4 more
doaj   +3 more sources

A Danish Survey of Antihistamine Use and Poisoning Patterns

Basic & Clinical Pharmacology & Toxicology, 2017
The first-generation antihistamine, promethazine, became a prescription-only drug in Denmark as of December 2014. First-generation antihistamines are known to have a higher toxic potential than second-generation antihistamines.
L. Jensen, J. Rømsing, K. Dalhoff
semanticscholar   +2 more sources

Antihistamine poisoning

Antihistamines are commonly used to treat allergy, dizziness and nausea. The sedating antihistamines are non-specific in their actions and often have marked anticholinergic effects.
Thomas SHL
core   +9 more sources

Real-life experience of efficacy and safety of bilastine in the refractory cases of chronic spontaneous urticaria and its effect on the quality of life of patients

Indian Journal of Dermatology, 2021
Introduction: Second-generation H1-antihistamines (SGAHs) are the mainstay of treatment of chronic spontaneous urticaria (CSU). Bilastine, newer non-sedating SGAHs, was recently introduced in India after the approval of the Drugs Controller General of ...
Abhishek De, Kiran Godse, Dhiraj Dhoot, Aarti Sarda   +3 more
doaj   +1 more source

Expert opinion on the role of bilastine and bilastine-montelukast combination in the management of allergic rhinitis: An Indian perspective

The Journal of Association of Chest Physicians, 2023
In India, the burden of allergic rhinitis (AR) is enormous, comprising 55% of all patients with allergies. Intranasal corticosteroids are the recommended first-line therapy for patients with moderate-to-severe AR, particularly when nasal congestion is ...
Subir Jain, Sarika Verma, Santhalingam Balamurugan, K.R. Bharath Kumar Reddy, D.J. Christopher   +4 more
doaj   +1 more source